About this document

Downregulation of TAB182 Promotes Cancer Stem-Like Cell Properties and Therapeutic Resistance in Triple-Negative Breast Cancer Cells by njzak2024 is a document available to read on EtoBox.

This study investigates the role of TAB182 in triple-negative breast cancer (TNBC), revealing that its downregulation enhances cancer stem-like cell properties and contributes to therapeutic resistance. The research demonstrates that TAB182 acts as a potential tumor suppressor by inhibiting cell proliferation, migration, and invasion, while its deletion leads to increased resistance to drugs like olaparib and cisplatin. These findings suggest that targeting TAB182 may improve treatment outcomes for TNBC pat

Author

njzak2024

Language

EN